Home › Novartis' Japan Unit Violates Protocol During Tasigna Drug Trial
 

Keywords :   


Novartis' Japan Unit Violates Protocol During Tasigna Drug Trial

2014-01-18 20:08:43| Biotech - Topix.net

Research and development of Novartis AG 's cancer drug Tasigna hit a roadblock when employees of the company's Japanese subsidiary transferred results from the research institutes where the trial was conducted to the University of Tokyo Hospital, where the results were being analyzed, violating the study's protocol, The Wall Street Journal reported ... (more)

Tags: japan unit trial drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Public Advisory Number 18A
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Eastern North Pacific Tropical Weather Outlook
03.07Atlantic Tropical Weather Outlook
03.07Benefits of benchmarking in the pork industry
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Forecast Discussion Number 18
More »